Pharmacovigilance
Pharmacovigilance Overview
Aman Al-Jazeera Corporation maintains a structured Pharmacovigilance (PV) system to ensure continuous monitoring of the safety profile of pharmaceutical products distributed within the Yemeni market.
The system is designed to detect, assess, understand, and prevent adverse effects or any other drug-related problems, in coordination with healthcare professionals, regulatory authorities, and manufacturing partners.
This commitment supports patient safety, regulatory compliance, and responsible pharmaceutical distribution practices.
Pharmacovigilance System Components
Drug Safety Monitoring
Continuous monitoring of product safety and adverse drug reactions.
Reporting & Follow-up System
Structured process for receiving, evaluating, and following up safety reports.
Qualified PV Responsible Person
Dedicated trained professional responsible for pharmacovigilance activities and reporting coordination.
Adverse Event Reporting
Healthcare professionals, pharmacists, and patients are encouraged to report any suspected adverse drug reactions or product quality issues.
Reports are handled with confidentiality and evaluated according to pharmacovigilance guidelines.
Adverse Drug Reaction (ADR) Reporting Form
Pharmacovigilance Contact
For safety reporting or pharmacovigilance inquiries, please contact:
Sana’a – Republic of Yemen